HALEOSLABS vs NGLFINE: Stock Comparison

Haleos Labs Limited vs NGL Fine-Chem Limited

Live data: 22 July 2026, 3:07 PM IST • Source: NSE and company filings

NGL Fine-Chem Limited is the larger company by market capitalisation. Haleos Labs Limited shows a lower P/E and a higher dividend yield, while NGL Fine-Chem Limited shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Haleos Labs Limited and NGL Fine-Chem Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, HALEOSLABS is more favourable on 3 of 13 scored metrics and NGLFINE on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
NGLFINE is the larger company
₹2,015 Cr vs ₹484 Cr
P/E Ratio
HALEOSLABS has a lower P/E
27.94x vs 41.23x
P/B Ratio
HALEOSLABS has a lower P/B
2.27x vs 6.03x
EPS
NGLFINE has higher earnings per share
₹78.04 vs ₹57.3
Dividend Yield
HALEOSLABS has a higher dividend yield
0.1% vs 0.05%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 0%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 0%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
57.1% vs -15.7%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHALEOSLABSNGLFINE
SectorHealthcare
IndustryPharmaceuticals

Price

MetricHALEOSLABSNGLFINE
Live Price₹1,522.4₹3,260
Day Change-3.09%0.7%
Volume2815,953
52-Week High₹1,774₹3,329
52-Week Low₹1,181₹1,175.5
Distance from 52W High-14.18%-2.07%

Valuation

MetricHALEOSLABSNGLFINE
Market Cap₹484 Cr₹2,015 Cr
P/E Ratio27.94x41.23x
P/B Ratio2.27x6.03x
EPS₹57.3₹78.04
Book Value₹706₹532.95
Dividend Yield0.1%0.05%

Growth

MetricHALEOSLABSNGLFINE
Revenue Growth (TTM YoY)0%57.2%
EPS Growth (TTM YoY)0%1,539.8%
Qtr Sales Growth-15.7%57.1%
Qtr Profit Growth-85.2%2,398%

Profitability & Leverage

MetricHALEOSLABSNGLFINE
ROE8.44%15.7%
ROCE9.91%17%
Net Margin5.33%9.59%
Operating Margin13.4%14.5%
Debt to Equity0.52x0.33x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricHALEOSLABSNGLFINE
Promoter Holding72.11%72.74%
FII Holding0%0.03% 0.03 pp
DII Holding0.31% 0.01 pp0%
Public Holding27.58% 0.02 pp27.24% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Haleos Labs Limited and NGL Fine-Chem Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.